Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 8x8 Inc (EGHT) vs Nuwellis Inc (NUWE) Price & Performance

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

8x8 Inc vs Nuwellis Inc — how do they compare? 8x8 Inc trades at $2.11 (market cap $311.98M), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: 8x8 Inc is far larger — about 141.8× Nuwellis Inc's market cap, and 8x8 Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold 8x8 Inc for 16 Days and Nuwellis Inc for 26 Days on average.

EGHTNUWE
Market Cap
$311.98M$2.20M
Volume
1,639,086121,544
Sector
TechnologyHealth
52-Week High
$2.76$146.65
52-Week Low
$1.59$0.68
Typical Hold Time
16 Days26 Days
Enterprise Value
$578.90M-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

8x8 Inc

EGHT trades at $2.11, down 1.4% today, with a bullish technical signal supported by moving averages. The company shows improving fundamentals with three consecutive quarterly EPS beats and projected profitability in 2026. Recent news highlights cost-saving client wins and AI product growth, while analysts maintain a mixed consensus with a $19.77 price target representing significant upside potential.

The stock presents a high-risk, high-reward opportunity with strong revenue growth potential but faces challenges from negative net income and high debt levels. Key catalysts include continued earnings outperformance and AI platform adoption, while risks involve execution challenges and competitive pressures in the communications software sector.

Nuwellis Inc

NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.

While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EGHT

No sentiment data available yet.

NUWE
2% Buy98% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About 8x8 Inc

8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.

Read more on EGHT →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →